Tian-yi Jiang

Shanghai, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

The noncanonical function of liver-type phosphofructokinase potentiates the efficacy of HDAC inhibitors in cancer.

The noncanonical function of liver-type phosphofructokinase potentiates the efficacy of HDAC inhibitors in cancer.

Journal: Signal transduction and targeted therapy
Published: March 29, 2025

Current status and prospects of targeted therapy for cholangiocarcinoma based on molecular characteristics.

Current status and prospects of targeted therapy for cholangiocarcinoma based on molecular characteristics.

Journal: Cancer letters
Published: December 02, 2024

RNA polymerase II subunit 5-mediating protein limits TLR4-induced innate immune activation in macrophages by inhibiting IKKβ/NF-κB signaling during sepsis.

RNA polymerase II subunit 5-mediating protein limits TLR4-induced innate immune activation in macrophages by inhibiting IKKβ/NF-κB signaling during sepsis.

Journal: Cell communication and signaling : CCS
Published: October 29, 2024

Blocking the SIRPα-CD47 axis promotes macrophage phagocytosis of exosomes derived from visceral adipose tissue and improves inflammation and metabolism in mice.

Blocking the SIRPα-CD47 axis promotes macrophage phagocytosis of exosomes derived from visceral adipose tissue and improves inflammation and metabolism in mice.

Journal: Journal of biomedical science
Published: October 24, 2024

PTEN status determines therapeutic vulnerability to celastrol in cholangiocarcinoma.

PTEN status determines therapeutic vulnerability to celastrol in cholangiocarcinoma.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: March 20, 2024

Bortezomib in previously treated phosphatase and tension homology-deficient patients with advanced intrahepatic cholangiocarcinoma: An open-label, prospective and single-centre phase II trial.

Bortezomib in previously treated phosphatase and tension homology-deficient patients with advanced intrahepatic cholangiocarcinoma: An open-label, prospective and single-centre phase II trial.

Journal: Clinical and translational medicine
Published: January 19, 2024

Arsenic trioxide augments immunogenic cell death and induces cGAS-STING-IFN pathway activation in hepatocellular carcinoma.

Arsenic trioxide augments immunogenic cell death and induces cGAS-STING-IFN pathway activation in hepatocellular carcinoma.

Journal: Cell death & disease
Published: November 09, 2023

PTEN deficiency facilitates gemcitabine efficacy in cancer by modulating the phosphorylation of PP2Ac and DCK.

PTEN deficiency facilitates gemcitabine efficacy in cancer by modulating the phosphorylation of PP2Ac and DCK.

Journal: Science translational medicine
Published: July 12, 2023

PTEN Deficiency Facilitates Exosome Secretion and Metastasis in Cholangiocarcinoma by Impairing TFEB-mediated Lysosome Biogenesis.

PTEN Deficiency Facilitates Exosome Secretion and Metastasis in Cholangiocarcinoma by Impairing TFEB-mediated Lysosome Biogenesis.

Journal: Gastroenterology
Published: July 19, 2022

Gankyrin and TIGAR cooperatively accelerate glucose metabolism toward the PPP and TCA cycle in hepatocellular carcinoma.

Gankyrin and TIGAR cooperatively accelerate glucose metabolism toward the PPP and TCA cycle in hepatocellular carcinoma.

Journal: Cancer science
Published: May 03, 2022

Measurable Residual Disease Detected by Multiparameter Flow Cytometry and Sequencing Improves Prediction of Relapse and Survival in Acute Myeloid Leukemia.

Measurable Residual Disease Detected by Multiparameter Flow Cytometry and Sequencing Improves Prediction of Relapse and Survival in Acute Myeloid Leukemia.

Journal: Frontiers in oncology
Published: March 08, 2021

PTEN deficiency facilitates the therapeutic vulnerability to proteasome inhibitor bortezomib in gallbladder cancer.

PTEN deficiency facilitates the therapeutic vulnerability to proteasome inhibitor bortezomib in gallbladder cancer.

Journal: Cancer letters
Published: September 05, 2020
Showing 1-12 of 18

Last Updated: 09/26/2026